Cohera TissuGlu® Surgical Adhesive in the Management of Wound Drainage
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01526954|
Recruitment Status : Completed
First Posted : February 6, 2012
Last Update Posted : December 5, 2013
|Condition or disease||Intervention/treatment||Phase|
|Abdominoplasty||Device: TissuGlu Surgical Adhesive||Phase 2 Phase 3|
Fluid accumulation in dissected tissue planes has been a longstanding problem following surgical procedures. The common use of closed suction drains has been associated with infection risk, wound healing complications, additional scarring, and patient discomfort. Additionally, seroma formation after drain removal often requires invasive treatment. Therapies that can reduce fluid accumulation and decrease the need for drains will have a positive impact on surgical practice.
- To establish that the use of TissuGlu® Surgical Adhesive is a safe and effective alternative to drains (standard of care) for fluid management following abdominoplasty.
- To evaluate the impact of TissuGlu® Surgical Adhesive on post-operative invasive treatments, and seroma formation.
- To evaluate the impact of TissuGlu® Surgical Adhesive on post-operative subject satisfaction and quality of life.
- To document the type and duration of adverse events associated with TissuGlu® used during an abdominoplasty procedure as an alternative to drains.
Material and Methods:
A prospective randomized trial comparing standard wound closure technique with drains in 130 subjects (control group n=65) to standard wound closure techniques plus TissuGlu® and no drains (test group n=65) during Abdominoplasty.
For subjects randomized into the Test Group, TissuGlu® will be applied to one surface of the exposed tissue flap using the custom applicator during a standard abdominoplasty procedure followed by normal wound closure (suturing technique) without drain placement. The applicator device will deliver an array of drops spaced equidistant apart. The user may then reposition the device to the next area and repeat the application process. Each device will dispense approximately 5 ml of adhesive. It is expected that one 5 ml device will suffice for the average sized subject (400-500 sq cm tissue flap). The TissuGlu® is applied using the disposable applicator to the tissue surfaces to be adhered just prior to standard closure. The tissue is then approximated, and the wound is closed using standard suturing techniques. TissuGlu® will begin to cure upon exposure to moisture in the tissue. The cure process takes approximately 30-45 minutes.
Subjects that are randomized to the Control Group will undergo normal wound closure (suturing technique) and placement of two size 12 Blake drains.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||150 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Care Provider)|
|Official Title:||A Prospective, Randomized, Controlled, Single-blind, Multicenter Clinical Trial Evaluating the Safety and Efficacy of the Cohera TissuGlu® Surgical Adhesive in the Management of Wound Drainage as Compared to the Standard of Care Closure Techniques Following Abdominoplasty|
|Study Start Date :||April 2012|
|Actual Primary Completion Date :||September 2013|
|Actual Study Completion Date :||November 2013|
Experimental: TissuGlu Surgical Adhesive
Experimental Arm: standard of care plus TissuGlu Surgical Adhesive and no drains
Device: TissuGlu Surgical Adhesive
TissuGlu Surgical Adhesive to be used prior to closure of the large tissue flap in abdominoplasty cases.
No Intervention: Control- Standard of Care
Control Arm: standard of care plus drains and no TissuGlu Surgical Adhesive
- Time to reach drain removal criteria. [ Time Frame: Measured until drains are removed, up to 30 days post-op. ]Primary efficacy endpoint is time (days) to reach drain removal criteria of less than 30ml per 24hr period.